Chronic recurrent multifocal osteomyelitis and tofacitinib: a case series
- 17 August 2022
- journal article
- letter
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 62 (3) , e42-e44
Abstract
Aviya Lanis, Sadie Van Den Bogaerde, Yongdong Zhao; Chronic recurrent multifocal osteomyelitis and tofacitinib: a case series, Rheumatology, , keac461, https://Keywords
This publication has 7 references indexed in Scilit:
- Efficacy of pamidronate in children with chronic non-bacterial osteitis using whole body MRI as a marker of disease activityPediatric Rheumatology, 2019
- Tofacitinib in the management of active psoriatic arthritis: patient selection and perspectivesPsoriasis: Targets and Therapy, 2019
- Consensus Treatment Plans for Chronic Nonbacterial Osteomyelitis Refractory to Nonsteroidal Antiinflammatory Drugs and/or With Active Spinal LesionsArthritis Care & Research, 2018
- Treatment Response and Longterm Outcomes in Children with Chronic Nonbacterial OsteomyelitisThe Journal of Rheumatology, 2017
- Etanercept treatment in five cases of refractory chronic recurrent multifocal osteomyelitis (CRMO)Joint Bone Spine, 2015
- Aggressive Therapy Reduces Disease Activity without Skeletal Damage Progression in Chronic Nonbacterial OsteomyelitisThe Journal of Rheumatology, 2015
- Dramatic pain relief and resolution of bone inflammation following pamidronate in 9 pediatric patients with persistent chronic recurrent multifocal osteomyelitis (CRMO)Pediatric Rheumatology, 2009